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Introduction
Evidence for mammary epithelial stem cells derives from
studies of the glands from rodents, canines and humans.
In the human, genetic analysis [1] of contiguous portions
of individual human mammary ducts within the same
breast signifies their clonal derivation and forecasts the
existence of multipotent mammary epithelial cells in the
human breast [2–4]. This work was confirmed and
extended by the demonstration of a common loss of het-
erozygosity in normal cells in individual lobules within
breast tissue from patients with carcinoma, in duct-lobular
units from paraffin-embedded mammary tissue, and from
normal luminal and myoepithelial cell clones derived from
reduction mammoplasty patients [5–7].
Cell lines from canine mammary spindle-cell tumors exhib-
ited mixed phenotypes on transplantation but possessed
identical allelic patterns in microsatellite analysis, suggest-
ing that canine mammary tumors arise from pluripotent
stem cells [8].
Rat mammary glands contain a subpopulation of clono-
genic epithelial cells that, when transplanted, give rise
either to alveolar or ductal structures [9]. In quantitative rat
mammary cell transplantation studies, both alveolar and
ductal colonies were developed that support the conclu-
sion that both colony types are derived from a single
clonogenic mammary cell [10,11].
In the mouse, it was recently shown that the epithelial
population of a fully developed lactating mammary out-
growth in mice could consist of the progeny from a single
cell [12]. Serial transplantation of epithelial fragments
from the clonally derived gland demonstrated that the
subsequently generated outgrowths are also comprised
of progeny from the original antecedent. All epithelial cell
types were found to be present within these clonal
normal populations including luminal, myoepithelial,
ductal and lobule-committed epithelial progenitors and
fully competent mammary epithelial stem cells. These
observations demonstrate the presence of multipotent
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tissue-specific epithelial stem cells among the
parenchyma of the mouse mammary gland.
The prevailing view regarding stem cells is that they are
cells with the capacity for prolonged, if not unlimited, self-
renewal and that they can produce at least one type of
fully differentiated descendant. Between the stem cell and
its differentiated progeny, there may often be an intermedi-
ate population of committed progenitors with a restricted
differentiation potential and a limited capacity for self-
renewal. It has become increasingly clear that stem cells
do not exist in organs as independent units; rather, their
behavior and maintenance is dependent on signals
emanating from neighboring somatic cells [13,14]. In
mammalian epidermis, Notch/Delta signaling [15] and
c-myc activation [16] control important aspects of epider-
mal stem cell behavior. Likewise, in the mammary gland,
activation of Notch brings about severe limitation of stem
cell function by preventing the development of the secre-
tory epithelial cell lineage [17].
An important key to understanding stem cell activity and
persistence in adult organs is the determination of the
physical microenvironment and molecular milieu within
which the stem cell resides (stem cell niche), and the
determination of the conditions that allow for stem cell
expansion or directed differentiation of stem cell progeny.
Stem cell aging in clonal mammary
populations
In the author’s laboratory, clonal mammary populations
derived from outgrowths of individual mammary fragments
from old, multiparous donors were created and carried
through six transplant generations to growth senescence.
The purpose of the experiment was to establish the ‘reper-
toire’ of the original stem cell antecedent by evaluating its
clonogenic (stem cell) progeny through successive trans-
plantation generations toward reproductive senescence.
A calculation of the total number of new stem cells required
during repopulation of each individual outgrowth indicates
that 1012–1013 multipotent progenitors will be generated
anew from the original antecedent before growth senes-
cence is reached [12]. This number is reached because all
parts of each newly generated mammary gland are capable
of recapitulating glandular regeneration on subsequent
transplantation (reviewed in [18]).
Using this approach, several new characteristics of
mammary epithelial stem cells have been discovered. For
example, local stem cells within individual outgrowths
display different patterns of growth senescence when
propagated in impregnated hosts. In this scenario, a fully
competent implant produces a gland with full secretory
lobule development filling the fat pad. Senescing out-
growths may fail to produce full secretory lobular develop-
ment but generate a complete system of branching ducts
or, alternatively, may yield only secretory lobule develop-
ment in the absence of ductal branching morphogenesis.
This illustrates that, during growth senescence, multipo-
tent stem cells independently lose their capacity to origi-
nate the progeny necessary for lobular and ductal
morphogenesis. Consequently, the property of producing
progeny committed to either ductal or lobular morphogen-
esis is not only intrinsic to the mammary stem cell, but is
also subject to independent regulatory control (Smith GH,
Boulanger C, Strickland P, Daniel C, manuscript submit-
ted). Growth senescence of these cells may be reached
only after serial transplantation through multiple genera-
tions [19–21].
A prediction ensues that, in growth senescent popula-
tions, there will be an absence of stem cells. Previously,
epithelial cells with a unique ultrastructural morphology
were described among the mammary epithelium of rats
and mice [22,23], and were shown to be proliferation
competent. These distinctive cells are omnipresent at all
stages of mammary development and differentiation. It
was proposed that these ultrastructurally distinct epithelial
cells represent mammary stem cells. Careful examination
of fully senescent mammary epithelial populations reveals
the absence of these ultrastructurally distinct cells, sup-
porting the conclusion that they are indeed mammary
epithelial stem cells (Smith GH, Boulanger C, Strickland
P, Daniel C, manuscript submitted).
Mammary stem cell control of ductal
patterning
Our observations in the mouse mammary gland suggest
that multipotent progenitors can strictly limit the behavior
of their progeny within a given environment and instruct,
quite specifically, the extent to which these daughters can
react to the local surroundings. This capability is demon-
strated in experiments where it is shown that progenitors
from the same clonal population can produce, within the
same host, vastly different mammary ductal structures.
Subsequent transplantation indicates that the multipotent
progeny found in these disparate mammary ductal popula-
tions retains the specific capacity to reproduce their spe-
cific ductal pattern. Local mammary stem cells therefore
accommodate the capacity not only to control the specific
patterns of the branching ducts they produce, but also to
control the ability to convey this dominion to their stem cell
progeny (Smith GH, Boulanger C, Strickland P, Daniel C,
manuscript submitted).
Premalignant populations from regional
mammary stem cells
The mammary stem cells (clonogens) produce the cellular
and tissue diversity of the gland. As already discussed,
much of this configuration may be cell autonomous (i.e.
programmed by its progenitor, the stem cell). This conceptbecomes more fundamental when applied to the appear-
ance of mammary hyperplasia and other parenchymal
irregularities. The local tissue derangement is often
demonstrably monoclonal in humans and rodents
[5–7,24]. The present author hypothesizes that these cel-
lular lesions exhibit cell autonomous characteristics con-
ferred on them by the transformed local stem cell. In
support of this speculation, local regions of serially trans-
planted epithelial clones occasionally manifested focal
regions of hyperplastic lobular development. These lesions
proved to be clonal in origin and repeatedly produced
hyperplastic lobular mammary outgrowths on transplanta-
tion. One normal fragment, a fourth-generation transplant,
generated an aggressive mammary neoplasm in situ. This
growth was also composed of cells derived from the origi-
nal clonogen and spawned several metastases to the lung
of the tumor host. The lung lesions proved, as well, to be
composed of cells descended from the primary founder. It
therefore appears that premalignant and malignant clones
may constitute a lineage potential of aging mammary
epithelial stem cells (Smith GH, Boulanger C, Strickland
P, Daniel C, manuscript submitted).
Proliferative capacity of an individual
mammary stem cell
The capacity of a single multipotent mammary antecedent
to reproduce mammary gland growth through multiple
transplant generations is unprecedented and represents
direct evidence of the prodigious reproductive potential of
a single mammary stem cell in the gland of an aged multi-
parous mouse. The presence of such cells in the
mammary gland must represent an enormous risk to sub-
sequent mammary cancer development. A means to
reduce mammary cancer risk may thus be to limit the
reproductive capability of individual stem cells in situ.
Boulanger and Smith demonstrated that stem cell self-
renewal is curtailed in mice expressing transforming
growth factor-beta 1 (TGF-β1) from the whey acidic
protein (WAP) promoter in the differentiating progeny of
the mammary stem cell, resulting in early growth senes-
cence [25]. As a consequence, the subsequent risk for
mammary tumorigenesis in these glands is startlingly
reduced, as demonstrated by challenging TGF-β1 trans-
genic and wild-type sisters with mouse mammary tumor
virus and tabulating the total mammary tumor incidence
over 80 weeks. This observation provides a ‘proof of prin-
ciple’ that stem cell proliferative power (self-renewal) and
tumor risk are inversely related.
A new study [26] utilizing WAP-driven Cre and Rosa 26-fl-
stop-fl-LacZ mammary glands shows great promise for
further clarification of a possible stem cell niche in the
mammary gland. Cells whose reporter gene has been acti-
vated by expression of WAP-Cre appear in late preg-
nancy. A portion of this parity-induced epithelium survives
postlactation involution (~5–10% in primiparous females)
and accumulates on successive pregnancies, represent-
ing >60% of the total epithelium in multiparous females.
A similar accumulation does not occur in nulliparous
females, although activated cells appear transiently during
the estrus cycle. The new parity-induced population con-
tributes extensively to secretory epithelial development on
successive pregnancies. Transplantation of fragments or
dispersed cellular populations containing the activated
cells indicates that they may contribute extensively to the
resulting outgrowth in which they appear at regular inter-
vals throughout the branching ducts [26]. An intriguing
possibility is that these sites represent newly formed stem
cell niches. The LacZ reporter gene enables enrichment of
these cells by fluorescence-activated cell sorting, opening
the possibility of a more detailed examination of their bio-
chemistry and molecular biology. In addition, the behavior
of the parity-induced epithelium in WAP-TGF-β1 mice may
enlighten further the relationship between WAP-express-
ing somatic cells and the behavior of mammary stem cells.
Conclusions
The presented data and those of other workers indicate
that proliferative capacity resides in a small number of
cells (clonogens) among the mammary epithelium. The evi-
dence also supports the conclusion that transiently ampli-
fying, lineage-limited cells are produced from omnipotent
epithelial stem cells. Of interest is the observation that
genes expressed in the differentiating somatic cells may
modulate the proliferative lifespan of mammary stem cells.
The discovery of a new proliferation-competent epithelium,
tagged by WAP expression in the mammary glands of
parous females, creates an experimental model for examin-
ing the effects of somatic cell signaling on stem cell
behavior. Modulation of stem cell behavior holds excep-
tional promise for a new prophylactic approach for control-
ling mammary cancer risk. An important step towards the
achievement of this control will be the characterization of
the stem cell niche in the rodent mammary gland and, ulti-
mately, in humans.
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